Cargando…
Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD
Familial amyloid polyneuropathy (FAP) is an autosomal dominant disease characterized by deposition of amyloid related to the presence of mutations in the transthyretin (TTR) gene. TTR is mainly synthesized in liver, choroid plexuses of brain and pancreas and secreted to plasma and cerebrospinal flui...
Autores principales: | Teixeira, Anabela C, Saraiva, Maria J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823024/ https://www.ncbi.nlm.nih.gov/pubmed/23387326 http://dx.doi.org/10.1111/jcmm.12024 |
Ejemplares similares
-
Glial cells in familial amyloidotic polyneuropathy
por: Gonçalves, Nádia Pereira, et al.
Publicado: (2014) -
Transthyretin-related familial amyloidotic polyneuropathy—Progress in Kumamoto, Japan (1967–2010)—
por: ARAKI, Shukuro, et al.
Publicado: (2010) -
Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis
por: Hund, Ernst
Publicado: (2012) -
Familial amyloidotic polyneuropathy in Crete, Greece
por: Tzagournissakis, Minas, et al.
Publicado: (2015) -
Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
por: Contesse, Sebastián E Azorín, et al.
Publicado: (2015)